Novel Cyclic Phosphate Prodrug Approach for Cytochrome P450-activated Drugs Containing an Alcohol Functionality

Author： Huttunen Kristiina   Mähönen Niina   Leppänen Jukka   Vepsäläinen Jouko   Juvonen Risto   Raunio Hannu   Kumpulainen Hanna   Järvinen Tomi   Rautio Jarkko  

Publisher： Springer Publishing Company

ISSN： 0724-8741

Source： Pharmaceutical Research, Vol.24, Iss.4, 2007-04, pp. : 679-687

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Diallyl Sulfide: Potential Use in Novel Therapeutic Interventions in Alcohol, Drugs, and Disease Mediated Cellular Toxicity by Targeting Cytochrome P450 2E1

By  

Current Drug Metabolism, Vol. 16, Iss. 6, 2015-07 ,pp. : 486-503

Bentham Science Publishers

Access to resources Recommend Favorite

Cytochrome P450 and Anticancer Drugs

By  

Current Drug Metabolism, Vol. 7, Iss. 1, 2006-01 ,pp. : 23-37

Bentham Science Publishers

Access to resources Recommend Favorite

Cytochrome P450 Gene-directed Enzyme Prodrug Therapy (GDEPT) for Cancer

By  

Current Pharmaceutical Design, Vol. 8, Iss. 15, 2002-07 ,pp. : 1405-1416

Bentham Science Publishers

Access to resources Recommend Favorite

Cytochrome P450 3A polymorphisms and immunosuppressive drugs

By Thervet Eric   Legendre Christopher   Beaune Philippe   Anglicheau Dany  

Pharmacogenomics, Vol. 6, Iss. 1, 2005-01 ,pp. : 37-47

Future Medicine

Access to resources Recommend Favorite

Cytochrome P450-Activated Prodrugs: Targeted Drug Delivery

By  

Current Medicinal Chemistry, Vol. 15, Iss. 23, 2008-10 ,pp. : 2346-2365

Bentham Science Publishers

Access to resources Recommend Favorite